HOME >> BIOLOGY >> NEWS
Wound monitor 'sniffs out' infections

The University of Manchester has received 1m (1.67m) to develop a new device able to 'sniff out' harmful infections.

The funding will be used to create a non-invasive wound monitor to treat patients with severe burns, skin ulcers or gaping wounds.

The aim is to produce a device which is able to detect harmful bacteria in the air, which may signal the first signs of infection. When bacteria metabolises inside a wound molecules of that bacteria are emitted into the air.

Current methods rely on medical staff taking swabs from a wound and testing them in a lab, which can take several days.

Professor Krishna Persaud, of The University of Manchester's School of Chemical Engineering and Analytical Science, who will coordinate the European-wide project, said: "Current methods make it difficult to detect infections at an early stage and can be extremely invasive causing the patient a great deal of discomfort".

"Our aim is to produce a non-invasive system that can monitor the state of a patient's wounds simply by detecting bad bacteria in the air emitted from the wound. Using state of the sensors we will be able to detect and diagnose the presence of an infection almost instantaneously."

The device will use new hybrid sensor technology with a mobile laboratory-based multi-technology gas sensor array and pattern recognition system, enabling the rapid analyses of molecules in the air. It is envisaged that the monitor will be take the form of a mobile unit which sits alongside other monitoring equipment next to the patient.

Key applications for the device will include monitoring trauma injuries, chronic ulcers and in military field hospitals.

Manchester will coordinate a European team of engineers and medical experts, which will include consultants from the Department of Burns and Plastic Surgery at Wythenshawe Hospital (Manchester) and Kaunas Medical University Hospital (Lithuania). The three year project is funde
'"/>

Contact: Simon Hunter
simon.hunter@manchester.ac.uk
161-275-8387
University of Manchester
14-Mar-2006


Page: 1 2

Related biology news :

1. Wound botulism
2. Wounds may one day heal better, faster, due to new NIH-funded wound healing centers
3. Who needs environmental monitoring?
4. DNA repair proteins monitored at double-strand break
5. Marine scientists monitor longest mammal migration
6. Snowmelt monitored in the Baltic Sea watershed region in near real time
7. Want to monitor climate change? P-p-p-pick up a penguin!
8. Researchers urge monitoring of bone health during chemotherapy
9. New study shows promise of toxicogenomics in environmental monitoring
10. CellSearch System cleared for monitoring metastatic breast cancer
11. Magic marker monitors malicious movements

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Wound monitor sniffs out infections

(Date:7/13/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... focused on the growing mobile commerce market, announced ... for BEHAVIORAL-DIRECTED AUTHENTIATION METHOD AND SYSTEM. ... secure method to make payments.  With this patent, ... with its groundbreaking voice-direct payment patent application, with ...
(Date:7/9/2015)... 2015  Unchained Labs just can,t get enough ... Avid Nano. Avid Nano designs, develops and manufactures ... Also today, Unchained Labs UNcaged the ... use protein sizing system. The pUNk is a ... size, size distribution, aggregation population and molecular weight. ...
(Date:7/8/2015)... , N.J. and NEW YORK , ... and Guidepoint today announced BD & ... healthcare companies with free access to Guidepoint,s expert network ... start-ups that are developing cutting-edge technologies to improve healthcare ... dedicated Guidepoint research manager, each start-up entrepreneur will be ...
Breaking Biology News(10 mins):NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3
(Date:7/30/2015)... , ... July 30, 2015 , ... ... advanced fluid applications and designed for continuous operation up to 1500 bar. The ... ensuring safety, efficiency, and preventing toxic contamination. , The Pony™ NS2006L homogenizer is ...
(Date:7/29/2015)... CER / 20% of sales) led the regional performance in the second quarter ... as solid contributions from Korea, India and ... / Africa (Q2 2015: +3% CER / ... Turkey and the United Kingdom . The Americas ... sales, on demand across all customer classes. The top seven emerging markets (Q2 ...
(Date:7/29/2015)... 29, 2015 Research ... addition of the "Global Biosimilars Market, 2015 ... The Global Biosimilars Market, 2015 - 2025, ... growing biosimilars market. With the blockbuster biologics losing ... costs, biosimilars are being viewed as viable substitutes ...
(Date:7/29/2015)... July 29, 2015  Indivior PLC (LON: INDV) today ... nasal spray was accepted and received Priority Review by ... treatment of opioid overdose. This naloxone nasal spray comes ... for optimal absorption into the nasal mucosa. 1 ... so individuals may be better equipped to help an ...
Breaking Biology Technology:GEA Announces the Pony™ NS2006L… a Self-contained, High Pressure Lab Homogenizer for Product Development Ensuring Maximum Efficiency and Safety 2QIAGEN Reports Results for Second Quarter and First Half of 2015 2QIAGEN Reports Results for Second Quarter and First Half of 2015 3QIAGEN Reports Results for Second Quarter and First Half of 2015 4QIAGEN Reports Results for Second Quarter and First Half of 2015 5QIAGEN Reports Results for Second Quarter and First Half of 2015 6QIAGEN Reports Results for Second Quarter and First Half of 2015 7QIAGEN Reports Results for Second Quarter and First Half of 2015 8QIAGEN Reports Results for Second Quarter and First Half of 2015 9QIAGEN Reports Results for Second Quarter and First Half of 2015 10Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 2Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 3Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 3Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 4Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 5
Cached News: